Top 50 Medical Device Startup Investors in Asia in January 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in Asia. We rank investors based on the number of investments they made in Medical device companies from Asia. We update this investor list every month.Top 50 Medical Device Startup Investors in Asia in January 2025
We help founders build enduring companies.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- SoSoValue — SoSoValue is a groundbreaking technology that changes the way investors access and evaluate cryptocurrency data. The company intends to level the playing field by ensuring equal access to cutting-edge data technology and insights. SoSoValue leverages strong AI capabilities to provide extensive research tools, real-time data, and a thrivingcommunity for collaborative growth.
- Kast — Kast Finance provides open access, financial freedom, and rapid gratification services.
- GCL Optoelectronics — GCL Optoelectronics is a supplier of perovskite solar modules, focusing on the R&D and production of perovskite solar modules.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.
Show more
Investment focus
- Manufacturing, Health Care, Software
- Series A, Series B, Angel
- China, Hong Kong, United States
Portfolio highlights
- Hohem — Hohem is a world-leading brand dedicated to AI tracking gimbals for video shooting, providing consumer and professional stabilizers for smartphones and cameras.
- Zibo Xincai — Zibo Xincai is an integrated circuit manufacturing company that focuses on the development, manufacturing, and sales of core materials for semiconductor packaging.
- Hengtuogao — Hitop Pneumatic Machinery specializes in the development, production, and distribution of pneumatic and electric actuators, grippers, and a wide range of components suitable for industrial automation. The company focuses on providing solutions that enhance efficiency and productivity in various industrial settings. With a commitment to innovationand quality, Hitop offers products designed to meet the diverse needs of its customers. The company's portfolio includes a comprehensive selection of automation machinery that caters to different sectors, ensuring that clients have access to the tools necessary for optimizing their operations.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- StepStar — The goal of Stepstar is to "Ten Times the Possibility of Everyone" through Intelligent Step. Step Star firmly creates its own super model and actively uses important resources like
- Zhipu AI — Zhipu AI is a data company developing an AI-based large model platform to provide API services. It includes a variety of smart application products such as the scientific and technological information analysis engine and AI cognitive engines to allow users to leverage AI-powered tools to reduce manual labor in digital tasks.
- XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Taiwan
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
- Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
BIOCHING CAPITAL is an investment management firm.
Show more
Investment focus
- Medical Device, Biotechnology, Medical
- Angel, Series A, Seed
- China
Portfolio highlights
- Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
- Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
- Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Syneron — Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals.
- Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
- Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Angel, Series B
- China
Portfolio highlights
- MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
- Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
- LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
- Chuangrui Spectrum — Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.
- TBSTest Technology — Yuexin Technology is a semiconductor test equipment developer specializing in R&D, production and sales of ultra-large-scale integrated circuit test equipment (ATE). Its main product is SOC test equipment, which is mainly for enterprise users of integrated circuit design, production, packaging and testing. Integrated circuit test equipment andsolutions.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Seed, Series A, Series B
- India, China, Canada
Portfolio highlights
- LegitQuest — An online legal research platform with Indian case laws. Research on Indian Cases, Judgments & Acts with AI enabled, User friendly product features.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
- Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
Jan joined Index in 2010, and is a London-based partner, focusing on fintech and information/data services across all stages of growth.He is one of Index Ventures’ leading fintech investors, working with the founders of Adyen, Credit Benchmark, Robinhood and TransferWise. In all, Index has backed more than two dozen fintech companies, withmore than $400 million. Jan has also led Index investments and is on the boards of Beamery, Collibra, SafetyCulture and Silverfin.Before he joined Index, Jan was at General Atlantic in London, where he worked on investments in Kaspersky Lab, Northgate Information Solutions and Torex Retail. He also worked in the M&A, TMT and Capital Markets divisions at Morgan Stanley. Jan is a graduate of Oxford University, and holds an MBA with Distinction from INSEAD.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Seed
- China, United States, Mexico
Portfolio highlights
- MacroLux — MacroLux operates as a medical technology company focusing on endoscopic interventional business. MacroLux develops endoscopic interventional therapy solutions and promote them to the majority of medical customers.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
- Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
- Software, Internet, E-Commerce
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
- ChainOpera AI — ChainOpera AI - The Blockchain and Protocol for Co-owning and Co-creating Decentralized AI Apps and Agents for Humanity, Backed by Federated AI OS and Platform
- Yin Gong Technology — Yin Gong Technology develops energy storage technology. It is an innovative battery technology developer in the green technology field.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
- Puju Biotechnology — PuJu Biotech focuses on developing an engineering process platform for bioactive filling materials and is dedicated to continuously launching world-class high-end regenerative medicine material products to benefit the vast number of people seeking beauty, as well as providing new material solutions for medical beauty and anti-aging for all agegroups.
- Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.
Show more
Investment focus
- Manufacturing, Internet, Software
- Series A, Series B, Series C
- China, India, United States
Portfolio highlights
- Hohem — Hohem is a world-leading brand dedicated to AI tracking gimbals for video shooting, providing consumer and professional stabilizers for smartphones and cameras.
- Zhuling Technology — Zhuling Technology is a robotics company that specializes in construction robot machines and core hardware and technology solutions.
- Guanchen Biotechnology — Guanchen Biotechnology is a developer of innovative cosmetic ingredients.
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Singapore
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.
- Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more
Investment focus
- Manufacturing, Biotechnology, Robotics
- Funding Round, Seed, Series A
- Japan, Singapore, India
Portfolio highlights
- Revorf — Revorf analyzes data and develops AI-related to infectious diseases and healthcare.
- MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
- Emulsion Flow Technologies — Emulsion Flow Technologies offers rare metal recycling, utilizing emulsion flow technology, emulsion.
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
- Zhongcheng Technology — Zhongcheng Technology is a centralized lubrication system developer that focuses on the research and development, manufacturing, sales, and technical services of centralized lubrication systems.
- Titanium Robotics Technology — Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Gecipe — Gecipe is a video service for e-sports players.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
- Renalys Pharma — Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
Taiyu Investment is an investment firm.
Show more
Investment focus
- Medical, Medical Device, Biotechnology
- Series A, Angel, Seed
- China
Portfolio highlights
- NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
- Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more
Investment focus
- Manufacturing, Electronics, Semiconductor
- Series A, Series B, Funding Round
- China, Hong Kong, United States
Portfolio highlights
- Vulcan — Vulcan is an engineering ceramics technology company that specializes in manufacturing mechanical seals and its materials.
- Xingwei Technology — Xingwei Technology is a high-tech enterprise focusing on high-end equipment, develops and manufactures high-performance Machine equipment and motion control systems. .
- Chasing Light Technology — Chasing Light provides organic semiconductor technology designed for the photovoltaic industry. Their organic semiconductor materials and their optoelectronic devices have shown application potential in the semiconductor field due to many advantages such as low cost, easy performance adjustment, flexibility, thinness, and transparency.
SND Ventures Group is a venture capital and private equity firm specializing in seed investments.
Show more
Investment focus
- Manufacturing, Semiconductor, Health Care
- Series A, Series B, Seed
- China
Portfolio highlights
- Edrive Space — Edrive Space develops aerospace propulsion systems for the aerospace industry. Edrive Space's electrothermal micro-propulsion products are suitable for the rapid orbiting and networking of micro-nano satellites, as well as emergency collision avoidance of space debris and active deorbit and other application scenarios, it is well adapted tothe needs of low cost, standardization, and batch networking of micro-nano satellites.
- Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
- Kunlun Precision — Kunlun Precision is a laser precision manufacturing service provider that focuses on the design integration and control system development of laser extreme advanced manufacturing equipment and devices, as well as supplying cross-scale laser manufacturing systems.
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Angel
- China, Hong Kong, United States
Portfolio highlights
- Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
- Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
- Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more
Investment focus
- Health Care, Internet, Medical
- Funding Round, Seed, Series A
- Japan, United States, Ethiopia
Goldport Capital is a Shenzhen-based asset management company.
Show more
Investment focus
- Manufacturing, Medical, Semiconductor
- Series A, Seed, Series B
- China
Portfolio highlights
- Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
- Fast Photonics — Fast Photonics specializes in the development and manufacturing of high-speed optical transceivers. The company offers a range of products designed for various applications in the field of optical communication. With a focus on innovation, Fast Photonics aims to provide solutions that meet the evolving needs of data transmission and communicationnetworks. The company holds ISO certification, emphasizing its commitment to quality and standards in manufacturing processes. Fast Photonics serves as an OEM/ODM/JDM partner, offering customized solutions to meet specific customer requirements. The company's expertise in optical technology makes it a key player in the industry, catering to the demands for faster and more efficient data communication.
- Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.
SZHTI Group is a company that provides asset management and financing services.
Show more
Investment focus
- Manufacturing, Electronics, Semiconductor
- Series A, Angel, Funding Round
- China, United States
Portfolio highlights
- StarDetect — StarDetect is a space-based computing platform that provides full-process satellite-based intelligent application service solutions.
- Ruibo Automation — Ruibo Automation is a high-tech inventive firm that specializes in Press-Fit pin process automation equipment. It combines independent research and development, manufacturing, and sales.
- Sanyuan Aerospace — Sanyuan Aerospace is an aerospace service provider with a core business in space operation technologies, space operation-related equipment development, and space on-orbit service business operations.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- China, United States, Hong Kong
Portfolio highlights
- Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Simcere Pharma — Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Seed
- China
Portfolio highlights
- JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
- Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
- Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, China
Portfolio highlights
- Taian — Taian, which specializes in bridal industry services and software. They also provide ''Concept Marry,'' which allows couples to design invites and seating charts that match their wedding theme, as well as display guest information on Oiwaii.
- greenase — greenase is a manufacturer and seller of processed agricultural products.
- Grand Central — Grand Central is a consulting company specializing in the sales field.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
- Artificial Intelligence, Medical, Biotechnology
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.
- Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
- Molar Intelligence — Molar Intelligence is a professional artificial intelligence data service provider.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Germany
Portfolio highlights
- Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
- ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
- Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more
Investment focus
- Health Care, Manufacturing, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Jiongyi Electronics — Jiongyi Electronics is a developer of automotive brake products, focusing on the development of automotive brake product technology.
- Shengyin Optoelectronics — Shengyin Optoelectronics is a platform-based micro-nano manufacturing firm that creates ornamental films for electrical appliances and portable electronics.
- Junhemeng Biopharmaceutical — Junhemeng is a research and development company of recombinant protein drugs.
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Taiyu Investment is an investment firm.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Seed, Angel
- China
Portfolio highlights
- Immorna — Immorna specializes in the production of RNA-based therapeutics.
- ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
- Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Angel
- China
Portfolio highlights
- Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
- Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
- Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
Catalysing smart monies into Singapore-based, early-stage technology startups.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Seed, Series A, Funding Round
- Singapore, United States, Hong Kong
Portfolio highlights
- DiMuto — DiMuto is a platform facilitating collaborative commerce that provides supply chain visibility. They provide global supply chains with a trade technology platform built on 4Ts: Tracking, Tracing, Transparency and Trust – thus demystifying global trade and enabling collaborative commerce. The DiMuto Track & Trace blockchain platform createsend-to-end trade visibility and forms building blocks for further value creation in trade financing, product marketing, and data analytics.DiMuto is founded by executive chairman Mr Gary Loh, who is also the Executive Chairman of First Alverstone Group.
- Aevice Health — Meet our AeviceMD, all-in-one sensor to deliver hospital-quality insights, right from home.
- Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
- Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.
Show more
Investment focus
- Biotechnology, Medical, Manufacturing
- Series A, Funding Round, Series B
- Japan, United States, United Kingdom
Portfolio highlights
- OOYOO — OOYOO Co., Ltd. is a DeepTech venture that combines international entrepreneurial spirit, and a 'Made In Japan' excellence, to bring the latest innovations in clean technology to society for a smarter, cleaner, and more mobile world.
- Visban — Visban is a technology company that specializes in utilizing mmWave signals for connectivity both indoors and outdoors. Their primary focus is on providing reliable and fast network solutions that eliminate dead spots and offer uninterrupted connections. By utilizing mmWave signals, Visban can achieve this with fewer base stations, leading to moreenergy-efficient operations and extended battery life for mobile devices on their network.
- Orbital Lasers — Orbital is a space tech company that provides space debris business to remove debris and a satellite LiDAR business to provide surface data.
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
- Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
- Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- Mianbi Smart — Mianbi Smart enables large-scale model acceleration and application execution using artificial intelligence.
- Ultron Photonics — Altra Photonics is committed to developing the world's most advanced femtosecond laser systems, providing you with reliable and stable ultrafast lasers and various ultrafast laser machines, devices and application solutions to help you create higher value.
NUS Enterprise provides an entrepreneurial and innovative dimension to the National University of Singapore’s core research and educational activities.By encouraging the entrepreneurial spirit, partnering for success, and nurturing future entrepreneurial leaders, NUS Enterprise aims to make a positive impact on Singapore’s economy and beyond.This is done through three key thrusts: entrepreneurship support, industry engagement and partnerships, and experiential education.NUS Enterprise was founded in 2001 and is based in Singapore.
Show more
Investment focus
- Information Technology, Health Care, Software
- Pre-Seed, Grant, Seed
- Singapore, Turkey, United States
Portfolio highlights
- YoRipe — YoRipe helps household to enjoy easy, healthy, and personalized cooking while empowering real time personalized marketing for FMCGs and retailers. The mobile platform brings more efficient marketing and actual shopper behavior insights to brands and stores. YoRipe’s aim is to make managing grocery at home more pleasant and efficient to save timeand money.YoRipe gives recipes for diet, allergies, and cravings. This mobile app also tracks food and send reminders before they expire whenever and wherever.
- Guardara — The most comprehensive negative testing / fuzz testing platform to hunt down bugs and zero-day vulnerabilities.
- Responsible Cyber with IMMUNE — Responsible Cyber Landing Page
Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more
Investment focus
- Manufacturing, Information Technology, Health Care
- Series A, Series B, Seed
- China, Japan, United States
Portfolio highlights
- TRUGO TECH — TRUGO TECH focuses on the research, development, and manufacturing of wire-controlled chassis. ESC and ABS are the main products of QianGu Technology
- Yaoyu Vision — Yaoyu Vision is a provider of SALM algorithms and chips, specializing in research, development, and design. It primarily offers a complete set of 6DoF solutions based on self-developed chips for the AR/VR headset sector, including head 6DoF positioning, hand 6DoF positioning, and cloud mapping.
- Zhongke Caixiang — Zhongke Caixiang is committed to delivering the most innovative high-end data acquisition tools and equipment.
Insight Capital is a venture capital firm focused on early-stage investment.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Series C
- China
Portfolio highlights
- Amity Corporation — Discover Amity, where we create digital solutions that help organizations, teams and individuals achieve more through technology and social innovation.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- elleThermo — elleThermo aims to implement Semiconductor-Sensitised Thermal Cells (STCs), an energy conversion technology that can generate electricity from unused waste heat above room temperature.
- NIHON AGRI — Exportation of Japanese agricultural products is currently small in volume. While Japanese farmers aspire to export their products to foreign countries for more people to enjoy and local consumers universally share the positive perception of the quality of Japanese agricultural products, issues such as price, communication, and logistics hinder theexpansion of exportation.They aim to solve these issues and satisfy the needs of both Japanese farmers and global consumers which are so clearly evident but devastatingly unmet.
- Japan Carbon Cycle Lab — Japan Carbon Cycle Lab is a technology company that focuses on the research and development of CO2 capture and recycling techniques.
FFG Venture Business Partners is a large-scale enterprise that offers in traditional regional bank venture capital.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Deltan — Deltan is a Minato-based orthodontic service provider.
- ACCEL Stars — ACCEL Stars is a fitness and wellness firm that offers sleep diagnosis and examinations like sleep health, hygiene and medical devices.
- KOALA Tech — Koala Tech Inc. is an innovative high-tech startup company, whose goal is to pioneer practical applications of the world's first organic semiconductor laser diode that has been realized in the Center for Organic Photonics and Electronics Research (OPERA) at Kyushu University.
Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.
Show more
Investment focus
- Software, E-Commerce, Artificial Intelligence
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
- Zhihe Computing — Zhihe Computing is an AI intelligent computing company that develops high-performance, scalable AI intelligent computing CPUs and RISC-V processors.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
At SGInnovate, our mission is to help entrepreneurial scientists build Deep Tech startups to solve the world hardest problems.
Show more
Investment focus
- Artificial Intelligence, Information Technology, Software
- Seed, Series A, Convertible Note
- Singapore, United States, Canada
Portfolio highlights
- DiMuto — DiMuto is a platform facilitating collaborative commerce that provides supply chain visibility. They provide global supply chains with a trade technology platform built on 4Ts: Tracking, Tracing, Transparency and Trust – thus demystifying global trade and enabling collaborative commerce. The DiMuto Track & Trace blockchain platform createsend-to-end trade visibility and forms building blocks for further value creation in trade financing, product marketing, and data analytics.DiMuto is founded by executive chairman Mr Gary Loh, who is also the Executive Chairman of First Alverstone Group.
- TeamSolve — TeamSolve is a pioneer in smart water analytics and digital water, building innovative solutions with the most forward-thinking utilities in the world.
- NEU Battery Materials — NEU provides a cleaner and more sustainable recycling solution for lithium-ion batteries. Contact us for your lithium battery recycling needs!
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
- Software, Manufacturing, Information Technology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Mufan Power — Mufan Power is a new energy high-tech enterprise in the field of turbomachinery. It is committed to the development of a new generation of zero-carbon hydrogen power generation technologies and products. Its main products are hydrogen gas turbines, which can be used in distributed energy and data centers. , rail transit, ship power, vehicle power,energy storage peak shaving and other carbon neutral scenarios.
- Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
- Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT
Investors by industry
Consumer
Hardware
Climate
Proptech
Gaming
Google
Marketplace
Biotech
Impact
Community
Energy
FinTech
Artificial intelligence
Health Care
EdTech
Sustainability
Venture Capital
Real Estate
Retail
Clean Energy
Food and Beverage
B2B
Video Games
Web3
Photography
Education
Big Data
Finance
Financial Services
Payments
Beauty
Publishing
Infrastructure
Organic Food
Social Network
Social Media
Digital Media
Art
Medical
Android
Franchise
Mobile
Local
Music
Legal
Enterprise Software
eSports
Construction
Sports
Internet
Wellness
Email
Manufacturing
Recruiting
Mobile Advertising
Travel
Hospitality
Cannabis
Fitness
Biotechnology
Platforms
Wine And Spirits
Automotive
Social
Medical Device
Crowdfunding
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
Canada
United States
New Zealand
South Korea
Ireland
India
Australia
Africa
Sri Lanka
Europe
Middle East
China
Qatar
Vietnam
Armenia
Oceania
Brazil
Indonesia
Asia
South Africa
Spain
Saudi Arabia
Japan
Singapore
LATAM
Estonia
Bermuda
Gibraltar
Belarus
Croatia
Ethiopia
Belize
Egypt
Georgia
France
Denmark
Costa Rica
Greece
Czech Republic
Hungary
Ecuador
Faroe Islands
Chile
Ghana
Liechtenstein
Finland
Mauritius
Lithuania
Italy
Philippines
Bahrain
Mali
Liberia
Algeria
Jersey
Malaysia
Israel
Malta
Hong Kong
Lebanon
Norway
Myanmar
Belgium
Morocco
Peru
Nicaragua
Mexico
Bulgaria
Panama
Kuwait
Senegal
Uruguay
Puerto Rico
Sweden
El Salvador
Barbados
Sierra Leone
Uganda
Dominican Republic
Slovenia
Bahamas
Taiwan
Togo
Seychelles
Zambia
Venezuela
Tajikistan
Zimbabwe
Russian Federation
Turkey
Tunisia
Uzbekistan
Thailand
Rwanda
Iceland
San Marino
Serbia
Tanzania
Ukraine
Portugal
Poland
Namibia
Nigeria
United Arab Emirates
Jamaica
Honduras
Isle of Man
Bolivia
Azerbaijan
Luxembourg
Iraq
Jordan
Albania
Pakistan
Bangladesh
Argentina
Romania
Grenada
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cameroon
Cyprus
Latvia
Oman
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Asia by industry
Restaurants
Crowdfunding
Venture Capital
Film
Mobile Advertising
B2B
Mobile Apps
Cryptocurrency
Finance
Payments
Food and Beverage
Video Games
Wine And Spirits
Medical Device
Email
Internet
Social Media
Social Network
Digital Media
Manufacturing
Art
Mobile
Android
Local
Google
Construction
Legal
Software
Sports
Enterprise Software
eSports
Fitness
CleanTech
Automotive
Hospitality
Travel
Recruiting
Platforms
FinTech
Biotechnology
Enterprise
Real Estate
Consumer
Health Care
Biotech
Climate
Impact
Energy
Sustainability
SaaS
Proptech
Marketplace
Hardware
Community
Gaming
Social Impact
Social
Retail
Infrastructure
Fashion
Beauty
Web3
Sporting Goods
Photography
Publishing
Big Data
Medical
Renewable Energy
Oil and Gas
Clean Energy
Financial Services
Transportation
Non Profit
Wellness
EdTech
Blockchain
Education
Franchise
Life Science
Music
Agriculture (agtech)
Media (entertainment)
Organic Food
InsurTech
Artificial intelligence